$8.28
In chiusura: Oct 7 EDT
$8.37
0.091.14%
Pre-mercato: 5:57 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Xeris Biopharma Holdings segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 7
Stima EPS
$0.010
Stima dei ricavi trimestrali
$74.26M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$246.03M
Analizza lo storico degli utili di Xeris Biopharma Holdings utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
XERS | Xeris Biopharma Holdings | -$0.11 | $0.01 | — | — | $54.27M | $74.26M | — | — | 11/07/2025 | |
XERS | Xeris Biopharma Holdings | -$0.10 | -$0.03 | -$0.01 | 66.67% | $48.06M | $64.75M | $71.54M | 10.49% | 08/07/2025 | |
XERS | Xeris Biopharma Holdings | -$0.14 | -$0.04 | -$0.06 | -50.00% | $40.64M | $57.61M | $60.12M | 4.36% | 05/08/2025 | |
XERS | Xeris Biopharma Holdings | -$0.10 | -$0.02 | -$0.03 | -50.00% | $44.39M | $58.54M | $60.10M | 2.66% | 03/06/2025 | |
XERS | Xeris Biopharma Holdings | -$0.09 | -$0.09 | -$0.11 | -22.22% | $48.32M | $51.43M | $54.27M | 5.52% | 11/08/2024 | |
XERS | Xeris Biopharma Holdings | -$0.14 | -$0.11 | -$0.10 | 9.09% | $36.89M | $45.81M | $46.51M | 1.53% | 08/08/2024 | |
XERS | Xeris Biopharma Holdings | -$0.12 | -$0.12 | -$0.14 | -16.67% | $33.20M | $41.81M | $40.64M | -2.80% | 05/09/2024 | |
XERS | Xeris Biopharma Holdings | -$0.10 | -$0.10 | -$0.10 | 0.00% | $33.14M | $43.55M | $44.39M | 1.93% | 03/06/2024 | |
XERS | Xeris Biopharma Holdings | -$0.16 | -$0.12 | -$0.09 | 25.00% | $29.73M | $41.08M | $48.32M | 17.62% | 11/09/2023 | |
XERS | Xeris Biopharma Holdings | -$0.19 | -$0.13 | -$0.14 | -7.69% | $25.26M | $34.84M | $36.89M | 5.89% | 08/08/2023 | |
XERS | Xeris Biopharma Holdings | -$0.25 | -$0.17 | -$0.12 | 29.41% | $22.07M | $30.76M | $33.20M | 7.92% | 05/09/2023 | |
XERS | Xeris Biopharma Holdings | -$0.42 | -$0.16 | -$0.10 | 37.50% | $21.43M | $31.04M | $33.14M | 6.78% | 03/08/2023 | |
XERS | Xeris Biopharma Holdings | -$0.39 | -$0.16 | -$0.16 | 0.00% | $11.04M | $29.12M | $29.73M | 2.08% | 11/09/2022 | |
XERS | Xeris Biopharma Holdings | -$0.41 | -$0.20 | -$0.19 | 5.00% | $8.84M | $25.53M | $25.26M | -1.06% | 08/10/2022 | |
XERS | Xeris Biopharma Holdings | -$0.30 | -$0.25 | -$0.25 | 0.00% | $8.05M | $23.59M | $21.91M | -7.12% | 05/11/2022 | |
XERS | Xeris Biopharma Holdings | -$0.41 | -$0.24 | -$0.42 | -75.00% | $7.09M | $18.90M | $21.43M | 13.38% | 03/10/2022 | |
XERS | Xeris Biopharma Holdings | -$0.35 | -$0.37 | -$0.39 | -5.41% | $9.45M | $11.03M | $11.04M | 0.05% | 11/10/2021 | |
XERS | Xeris Biopharma Holdings | -$0.63 | -$0.30 | -$0.41 | -36.67% | $2.03M | $9.54M | $8.84M | -7.39% | 08/05/2021 | |
XERS | Xeris Biopharma Holdings | -$0.89 | -$0.34 | -$0.30 | 11.76% | $1.79M | $7.47M | $8.05M | 7.78% | 05/13/2021 | |
XERS | Xeris Biopharma Holdings | -$1.23 | -$0.38 | -$0.41 | -7.89% | $1.86M | $8.21M | $7.09M | -13.65% | 03/09/2021 | |
XERS | Xeris Biopharma Holdings | -$1.22 | -$0.52 | -$0.35 | 32.69% | $314.00K | $4.48M | $9.45M | 110.89% | 11/09/2020 |
Xeris Biopharma Holdings (XERS) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $-0.01 | $-0.03 | 66.7 % |
| Q1 | 2025-05-08 | $-0.06 | $-0.04 | -50.0 % |
| Q4 | 2025-03-06 | $-0.03 | $-0.02 | -50.0 % |
| Q3 | 2024-11-08 | $-0.11 | $-0.09 | -22.2 % |
Xeris Biopharma Holdings (XERS) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $71.54M | $64.75M | 10.5 % |
| Q1 | 2025-05-08 | $60.12M | $57.61M | 4.36 % |
| Q4 | 2025-03-06 | $60.10M | $58.54M | 2.66 % |
| Q3 | 2024-11-08 | $54.27M | $51.43M | 5.52 % |
FAQ
Quando Xeris Biopharma Holdings (NASDAQ:XERS) riporterà gli utili?
Si prevede che Xeris Biopharma Holdings (XERS) fornisca risultati il novembre 7, 2025. Gli ultimi risultati sono stati pubblicati il agosto 7, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Xeris Biopharma Holdings (NASDAQ:XERS)?
L'EPS effettivo era $-0.01, che superato la stima di $-0.03.
Quali sono state le entrate di Xeris Biopharma Holdings (NASDAQ:XERS)?
Le entrate effettive sono state $71.5M, che superato la stima di $64.7M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.